title: Review of Acute Coronary Syndromes: Diagnosis and Management of ST-Elevation Myocardial Infarction.
abstract: Acute coronary syndrome is a life-threatening event that affects millions of people each year and accounts for a big portion of hospital visits. With an ever-growing elderly patient population, ischemic heart disease is more prevalent than ever before. It is paramount that physicians of all fields are cognizant of the various presentations of acute coronary syndrome (ACS), as its prompt diagnosis and treatment profoundly decreases mortality and morbidity. Under the American College of Cardiology Foundation and the American Heart Association, guidelines are published for the optimal management of patients with acute coronary syndromes. Guidelines are continuously evolving as more multicenter randomized trials, new medications and new technologies continue to change the way we treat acute coronary syndromes. The focus of this review is ST-elevation myocardial infarction and it provides answers to some of the fundamental questions through evidence-based guidelines.
authors.forename: Jimmy
authors.initials: J
authors.lastname: Yee
authors.forename: Naveen
authors.initials: N
authors.lastname: Rajpurohit
authors.forename: Muhammad A
authors.initials: MA
authors.lastname: Khan
authors.forename: Adam
authors.initials: A
authors.lastname: Stys
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D002317:Cardiovascular Agents / Q000008:administration & dosage; D019468:Disease Management; D004562:Electrocardiography; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D010102:Oxygen Inhalation Therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D013997:Time Factors
chemical_list: D002317:Cardiovascular Agents; D010975:Platelet Aggregation Inhibitors